Physician profile
Amy Lee Smith
NPI 1528620044
$452.09
in general payments reported to CMS, 2019-2025
10 companies · $93.92 in 2025
The $93.92 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $222 · 2023: $89.99 · 2024: $46.10 · 2025: $93.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $230.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $230.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $125.37 | 2022 | |
| Avanir Pharmaceuticals, INC. | $70.44 | 2022 | |
| Novartis Pharmaceuticals Corporation | $69.38 | 2023-2024 | |
| Tactile Systems Technology INC | $42.16 | 2025 | Flexitouch Plus, Nimbl |
| Sumitomo Pharma America, INC. | $35.21 | 2023 | Gemtesa |
| Integra Lifesciences Corporation | $32.23 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Lilly USA, LLC | $31.50 | 2023 | Mounjaro, Trulicity, Basaglar |
| Kite Pharma, INC. | $19.53 | 2025 | Yescarta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.11 | 2022 | |
| Impel Pharmaceuticals INC. | $12.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.